Streetbeat News

Products Services

CPRX

Catalyst Pharmaceuticals' partner DyDo Pharma has submitted a New Drug Application for FIRDAPSE in Japan for treating Lambert Eaton myasthenic syndrome. The submission to Japan's PMDA is based on positive interim data from a safety study. The review period may take at least nine months.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 11:31 am

AAPL

Apple Inc. (NASDAQ:AAPL) is rumored to introduce a new Capture Button on the iPhone 16, replacing the mmWave antenna's position and hinting at enhanced video recording features. Bloomberg's Mark Gurman suggests the button will offer haptic feedback and pressure recognition, potentially supporting advanced video and spatial capture. This aligns with earlier leaks about an additional button and could indicate significant progress in Apple's video technology, possibly to complement the Vision Pro headset.

Portfolio Pulse from Rounak Jain

December 18, 2023 | 11:10 am

KBR

KBR has partnered with The Henry M. Jackson Foundation to support neuroscience research focused on service members with traumatic brain injuries. The research will be conducted in collaboration with the Uniformed Services University and the University of California San Francisco.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 11:03 am

FWBI

First Wave BioPharma has announced the addition of latiglutenase, a Phase 3-ready oral biotherapeutic for celiac disease, to its late-stage clinical pipeline, which is focused on gastrointestinal diseases.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 11:00 am

FWBI

SNY

First Wave BioPharma Inc (FWBI) plans to acquire ImmunogenX in an all-stock transaction to enhance its GI disease pipeline. The deal is expected to close in H1 2024. FWBI's CEO will remain, with ImmunogenX's CEO becoming CMO. FWBI anticipates non-dilutive funding from a strategic pharma company for latiglutenase's U.S. rights and investor commitments for development post-closing. Latiglutenase, for celiac disease, is set for Phase 3 trials in H2 2024. FWBI also licensed Capeserod from Sanofi SA (SNY) for GI uses and enacted a 1-for-20 reverse stock split.

Portfolio Pulse from Vandana Singh

December 18, 2023 | 11:00 am

IBM

SWDAF

IBM has agreed to acquire StreamSets and webMethods from Software AG for €2.13 billion (~$2.3 billion) in cash to enhance its AI and hybrid cloud capabilities. The acquisition, funded by IBM's cash on hand, is expected to complete in Q2 FY24. IBM's cash and marketable securities stood at $11 billion at the end of Q3. The deal aims to integrate these platforms with IBM's watsonx AI and data platform, driving innovation and preparing businesses for AI.

Portfolio Pulse from Lekha Gupta

December 18, 2023 | 10:47 am

VNET

VNET Group, Inc. hosted representatives from the US-China Green Energy Council at its Taicang data center campus, highlighting its renewable energy infrastructure development. This event emphasizes VNET's commitment to sustainable energy practices within China's data center industry.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 10:14 am

AAPL

Apple Inc. has introduced 'Contingent pricing' for App Store developers, allowing them to offer subscription discounts to users who subscribe to multiple services. This feature enables developers to collaborate and provide discounts to users who are subscribed to another service, potentially by a different developer. The initiative aims to attract and retain subscribers, offering a win-win situation for users, developers, and Apple. In 2022, developers generated $1.1 trillion in sales through the App Store, with 90% of the revenue going to developers.

Portfolio Pulse from Rounak Jain

December 18, 2023 | 9:56 am

DOGE-USD

ETH-USD

MATIC-USD

Polygon Labs has ceased development on Polygon Edge, the open-source tool used for Dogechain development, shifting focus to Polygon CDK, a new blockchain framework utilizing zero-knowledge cryptography. This move may impact Dogechain's operations and future, as it relied on Polygon Edge, but many projects are expected to transition to the new Polygon CDK.

Portfolio Pulse from Mehab Qureshi

December 18, 2023 | 9:12 am

HIMX

Himax Technologies, Inc. (NASDAQ:HIMX) is set to debut its HX83132 series in-cell TDDI for LCD notebooks and HX85200 series on-cell touch controller for premium AMOLED notebooks at CES 2024. The event, which is the largest consumer electronics show, will take place in Las Vegas from January 9 to 12, 2024.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 9:04 am